Jacobs Levy Equity Management
BCAB

Jacobs Levy Equity Management’s BIOATLA INC BCAB Stock Holding History

Jacobs Levy Equity Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,962
Closed -$383K – 1078
2024
Q4 		$383K Buy
+12,962
New +$1.09M ﹤0.01% 847

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Jacobs Levy Equity Management's BCAB Position: Q1 2025 in Review

Jacobs Levy Equity Management sold out of BIOATLA INC (BCAB) in Q1 2025, closing a stake of 12,962 shares — an estimated $383K sold.

Jacobs Levy Equity Management first reported a position in BCAB in Q4 2024 and held it in 1 quarter. The position peaked at $383K in Q4 2024. 42 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

  • Jacobs Levy Equity Management reported no remaining BIOATLA INC position as of Q1 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 12,962 BIOATLA INC shares in Q1 2025, an estimated $383K.
  • Jacobs Levy Equity Management first reported a position in BIOATLA INC in Q4 2024 and held it in 1 quarter.
  • Jacobs Levy Equity Management's BIOATLA INC position peaked at $383K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held BIOATLA INC as of Q1 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2025, filed 15 May 2025.